Skip to main navigation menu Skip to main content Skip to site footer

Polycystic Kidney Disease: A Case Series

Enfermedad renal poliquística: serie de casos



Open | Download


Section
Case Reports

How to Cite
Gutierrez Vargas, M. C., & Ostos Alfonso, H. (2025). Polycystic Kidney Disease: A Case Series. Journal of Medicine and Surgery Repertoire. https://doi.org/10.31260/RepertMedCir.01217372.1526

Dimensions
PlumX
Citations
license

   


Henry Ostos Alfonso,

Doctor. Master in Genetics. University teacher.


Introduction: Polycystic disease is the most common kidney inherited disorder having a global prevalence of 1 in 10.000. Both phenotype and genotype are heterogenous with a Mendelian inheritance pattern, which allows it to be classified as autosomal dominant and recessive. Case reports: we report 5 cases, the first one featuring a new variant of the ITGA8 gene not described before, 3 featuring the autosomal dominant PKD1 gene and 1 case the autosomal recessive PKHD1 gene. Discussion and conclusion: our data illustrates ultrasonographic, molecular and laboratory findings which are helpful in elucidating the heterogeneous spectrum of the disease.


Article visits 10 | PDF visits 0


Downloads

Download data is not yet available.
  1. Montaña A, Patiño N, Larrate C, Zambrano FA, Martínez J, Lozano H, et al. Actualización en enfermedad renal poliquística. Rev Fac Med. 2018;66(1):107–16. http://dx.doi.org/10.15446/revfacmed.v66n1.60760
  2. Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4(1):50. http://dx.doi.org/10.1038/s41572-018-0047-y
  3. Colbert GB, Elrggal ME, Gaur L, Lerma E V. Update and review of adult polycystic kidney disease. Dis Mon. 2020;66(5):100887. http://dx.doi.org/10.1016/j.disamonth.2019.100887
  4. Menezes LF, Germino GG. The pathobiology of polycystic kidney disease from a metabolic viewpoint. Nat Rev Nephrol. 2019;15(12):735–49. http://dx.doi.org/10.1038/s41581-019-0183-y
  5. Luo L, Roy S, Li L, Ma M. Polycystic kidney disease: novel insights into polycystin function. Trends Mol Med. 2023;29(4):268–81. http://dx.doi.org/10.1016/j.molmed.2023.01.005
  6. Foo JN, Xia Y. Polycystic kidney disease: new knowledge and future promises. Curr Opin Genet Dev. 2019;56:69–75. http://dx.doi.org/10.1016/j.gde.2019.06.007
  7. Wicher D, Obrycki Ł, Jankowska I. Autosomal Recessive Polycystic Kidney Disease-The Clinical Aspects and Diagnostic Challenges. J Pediatr Genet. 2021;10(1):001–8. http://dx.doi.org/10.1055/s-0040-1714701
  8. Cordido A, Vizoso‐gonzalez M, Garcia‐gonzalez MA. Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease. Int J Mol Sci. 2021;22(12):6523. http://dx.doi.org/10.3390/ijms22126523
  9. Roediger R, Dieterich D, Chanumolu P, Deshpande P. Polycystic Kidney/Liver Disease. Clin Liver Dis. 2022;26(2):229–43. http://dx.doi.org/10.1016/j.cld.2022.01.009
  10. Müller RU, Messchendorp AL, Birn H, Capasso G, Cornec-Le Gall E, Devuyst O, et al. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrol Dial Transplant. 2022;37(5):825–39. http://dx.doi.org/10.1093/ndt/gfab312
  11. Gómez-Conde S, Dunand O, Hummel A, Morinière V, Gauthier M, Mesnard L, et al. Bi-allelic pathogenic variants in ITGA8 cause slowly progressive renal disease of unknown etiology. Clin Genet. 2023;103(1):114–118. http://dx.doi.org/10.1111/cge.14229
  12. Seeman T, Blažík R, Fencl F, Bláhová K, Obeidová L, et al. Ambulatory blood pressure and hypertension control in children with autosomal recessive polycystic kidney disease: clinical experience from two central European tertiary centres. J Hypertens. 2022;40(3):425–31. http://dx.doi.org/10.1097/HJH.0000000000002973
  13. Irazabal M V., Torres VE. Total Kidney Volume and Autosomal Dominant Polycystic Kidney Disease: A Long-Standing Relationship. Am J Nephrol. 2018;48(1):65–6. http://dx.doi.org/10.1159/000491026
  14. Park H, Paek JH, Kim Y, Park WY, Han S, Jin K. Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study. Medicine. 2022;101(47):E31838. http://dx.doi.org/10.1097/MD.0000000000031838
  15. Tian W, Chen N, Ye Y, Ma C, Qin C, Niu Y, et al. A genotype-first analysis in a cohort of Mullerian anomaly. J Hum Genet. 2022;67(6):347–352. http://dx.doi.org/10.1038/s10038-021-00996-w
  16. Abdul Majeed N, Font-Montgomery E, Lukose L, Bryant J, Veppumthara P, Choyke PL, et al. Prospective Evaluation of Kidney and Liver disease in Autosomal Recessive Polycystic Kidney Disease-Congenital Hepatic Fibrosis. Mol Genet Metab. 2020;131(1–2):267-276. http://dx.doi.org/10.1016/j.ymgme.2020.08.006
Sistema OJS 3.4.0.5 - Metabiblioteca |